Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Tibet Duo Rui Pharmaceutical
301075
5
Chengda Pharmaceuticals
301201
US Stock MarketDetailed Quotes
DSGN Design Therapeutics
- 3.860
- -0.350-8.31%
Close Mar 31 16:00 ET
219.10MMarket Cap-4.39P/E (TTM)
4.150High3.850Low88.25KVolume4.060Open4.210Pre Close345.03KTurnover0.35%Turnover RatioLossP/E (Static)56.76MShares7.77052wk High0.91P/B97.97MFloat Cap3.15052wk Low--Dividend TTM25.38MShs Float50.500Historical High--Div YieldTTM7.13%Amplitude1.940Historical Low3.909Avg Price1Lot Size
About Design Therapeutics Company
Design Therapeutics, Inc. operates as a biotechnology company that develops therapies for serious degenerative disorders. It is created to design, develop and commercialize a novel class of small molecule therapeutic candidates (GeneTACs) designed to directly address the underlying basis of genetic disease. The company was founded by Pratik Shah and Aseem Z. Ansari on December 18, 2017 and is headquartered in Carlsbad, CA.
Company Profile
SymbolDSGN
Company NameDesign Therapeutics
Listing DateMar 26, 2021
Issue Price20.00
Founded2017
CEODr. Pratik Shah, PhD
MarketNASDAQ
Employees54
Fiscal Year Ends12-31
Address6005 Hidden Valley Road,Suite 110
CityCarlsbad
ProvinceCalifornia
CountryUnited States of America
Zip Code92011
Phone1-858-293-4900
Websitehttp://www.designtx.com
Company Executives
- Name
- Position
- Salary
- Dr. Pratik Shah, PhD
- Chairperson of the Board, President, Chief Executive Officer and Principal Financial Officer
- 6.32M
- Dr. Sean Jeffries, PhD
- Chief Operating Officer
- 1.28M
- Dr. Jae B. Kim, M.D.
- Chief Medical Officer
- --
- Julie Burgess
- Chief Accounting Officer
- --
- Deepa Prasad
- Independent Director
- 94.20K
- John P. Schmid
- Independent Director
- 106.70K
- Dr. Simeon J. George, M.B.A.,M.D.
- Lead Independent Director
- 95.70K
- Dr. Rodney W. Lappe, PhD
- Independent Director
- 228.56K
- Dr. Heather Berger, PhD
- Independent Director
- 94.20K
- Dr. Arsani William, M.D.
- Independent Director
- 104.20K
Market Insights
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call